Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea
· Delayed Price · Currency is KRW
24,750
+100 (0.41%)
Aug 14, 2025, 3:30 PM KST
Onconic Therapeutics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Aug '25 Aug 13, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 272,723 | 176,537 | - | - | - |
| Enterprise Value | 227,754 | 152,373 | - | - | - |
| Last Close Price | 24650.00 | 16340.00 | - | - | - |
| PS Ratio | 9.27 | 11.90 | - | - | - |
| PB Ratio | 4.62 | 3.15 | - | - | - |
| P/TBV Ratio | 4.62 | 3.15 | - | - | - |
| EV/Sales Ratio | 7.74 | 10.27 | - | - | - |
| Debt / Equity Ratio | 0.00 | 0.01 | -0.06 | 0.00 | -0.02 |
| Debt / EBITDA Ratio | 0.10 | - | 0.13 | - | - |
| Debt / FCF Ratio | - | - | 0.12 | - | - |
| Asset Turnover | 0.59 | 0.30 | 0.62 | 0.00 | - |
| Quick Ratio | 11.65 | 10.61 | 0.71 | 1.06 | 36.08 |
| Current Ratio | 12.10 | 10.94 | 0.71 | 1.06 | 36.10 |
| Return on Equity (ROE) | 9.95% | -32.29% | - | - | - |
| Return on Assets (ROA) | 2.15% | -6.09% | 4.07% | -36.85% | - |
| Return on Capital (ROIC) | 2.31% | -11.81% | - | - | - |
| Earnings Yield | 1.68% | -4.58% | - | - | - |
| FCF Yield | -1.55% | -4.52% | - | - | - |
| Buyback Yield / Dilution | - | -1314.60% | 0.00% | -0.94% | - |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.